Skip to main content

Table 3 The Post-hoc analysis (least significant difference) comparing IGF-1 serum levels for each of the 6 CVMI stages

From: Serum IGF-1, IGFBP-3 and their ratio: Potential biochemical growth maturity indicators

CVMI Stage

CVMI Stage

Mean Difference

Significance

1

2

−27.5*

0.000(**)

3

−222.3*

0.000(**)

4

−151.5*

0.000(**)

5

−113.6*

0.000(**)

6

−27.5*

0.000(**)

2

1

27.5*

0.000(**)

3

−194.8*

0.000(**)

4

−123.9*

0.000(**)

5

−86.07*

0.000(**)

6

−.02

0.996(NS)

3

1

222.3*

0.000(**)

2

194.8*

0.000(**)

4

70.8*

0.000(**)

5

108.7*

0.000(**)

6

194.8*

0.000(**)

4

1

151.5*

0.000(**)

2

123.9*

0.000(**)

3

−70.8*

0.000(**)

5

37.9*

0.000(**)

6

123.9*

0.000(**)

5

1

113.6*

0.000(**)

2

86.07*

0.000(**)

3

−108.7*

0.000(**)

4

−37.9*

0.000(**)

6

86.04*

0.000(**)

6

1

27.5*

0.000(**)

2

0.02

0.996(NS)

3

−194.8*

0.000(**)

4

−123.9*

0.000(**)

5

−86.04*

0.000(**)

  1. (**) Highly significant (P < 0.01, P < 0.001),(*) Significant (P < 0.05), NS (Non significant)